WO2019233202A1 - 一种海藻膳食纤维冻及其制备方法 - Google Patents
一种海藻膳食纤维冻及其制备方法 Download PDFInfo
- Publication number
- WO2019233202A1 WO2019233202A1 PCT/CN2019/083608 CN2019083608W WO2019233202A1 WO 2019233202 A1 WO2019233202 A1 WO 2019233202A1 CN 2019083608 W CN2019083608 W CN 2019083608W WO 2019233202 A1 WO2019233202 A1 WO 2019233202A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- parts
- dietary fiber
- alginate
- seaweed
- servings
- Prior art date
Links
- 235000013325 dietary fiber Nutrition 0.000 title claims abstract description 63
- 241001474374 Blennius Species 0.000 title claims abstract description 38
- 235000015110 jellies Nutrition 0.000 title claims abstract description 29
- 239000008274 jelly Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title description 8
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000000843 powder Substances 0.000 claims abstract description 30
- 241000199919 Phaeophyceae Species 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229920001202 Inulin Polymers 0.000 claims abstract description 20
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 20
- 229940029339 inulin Drugs 0.000 claims abstract description 20
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 18
- 239000004375 Dextrin Substances 0.000 claims abstract description 16
- 229920001353 Dextrin Polymers 0.000 claims abstract description 16
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 16
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 16
- 229920000615 alginic acid Polymers 0.000 claims abstract description 16
- 235000019425 dextrin Nutrition 0.000 claims abstract description 16
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 16
- 239000001259 polydextrose Substances 0.000 claims abstract description 16
- 229940035035 polydextrose Drugs 0.000 claims abstract description 16
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229920002752 Konjac Polymers 0.000 claims abstract description 15
- 229940072056 alginate Drugs 0.000 claims abstract description 15
- 235000013312 flour Nutrition 0.000 claims abstract description 13
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 9
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 9
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 9
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 6
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 6
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000003349 gelling agent Substances 0.000 claims description 16
- 241001312219 Amorphophallus konjac Species 0.000 claims description 14
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 14
- 239000000252 konjac Substances 0.000 claims description 14
- 235000010485 konjac Nutrition 0.000 claims description 14
- 239000003292 glue Substances 0.000 claims description 12
- 239000000499 gel Substances 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 238000004659 sterilization and disinfection Methods 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 11
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 9
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 235000010413 sodium alginate Nutrition 0.000 claims description 9
- 239000000661 sodium alginate Substances 0.000 claims description 9
- 229940005550 sodium alginate Drugs 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 235000010408 potassium alginate Nutrition 0.000 claims description 6
- 239000000737 potassium alginate Substances 0.000 claims description 6
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 6
- 241000195493 Cryptophyta Species 0.000 claims description 5
- 159000000007 calcium salts Chemical class 0.000 claims description 5
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 5
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 5
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 4
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 4
- 238000000465 moulding Methods 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 238000013268 sustained release Methods 0.000 claims description 4
- 239000012730 sustained-release form Substances 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 229960003563 calcium carbonate Drugs 0.000 claims description 3
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 claims description 3
- 235000019982 sodium hexametaphosphate Nutrition 0.000 claims description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 2
- 235000010407 ammonium alginate Nutrition 0.000 claims description 2
- 239000000728 ammonium alginate Substances 0.000 claims description 2
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
- 239000001527 calcium lactate Substances 0.000 claims description 2
- 229960002401 calcium lactate Drugs 0.000 claims description 2
- 235000011086 calcium lactate Nutrition 0.000 claims description 2
- 229940095672 calcium sulfate Drugs 0.000 claims description 2
- 235000011132 calcium sulphate Nutrition 0.000 claims description 2
- 235000019820 disodium diphosphate Nutrition 0.000 claims description 2
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 claims description 2
- 229940038485 disodium pyrophosphate Drugs 0.000 claims description 2
- 239000000905 isomalt Substances 0.000 claims description 2
- 235000010439 isomalt Nutrition 0.000 claims description 2
- -1 isomalt oligosaccharide Chemical class 0.000 claims description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical group [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 2
- 229940048086 sodium pyrophosphate Drugs 0.000 claims description 2
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 10
- 206010010774 Constipation Diseases 0.000 abstract description 8
- 230000008855 peristalsis Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 235000021486 meal replacement product Nutrition 0.000 abstract description 2
- 235000012054 meals Nutrition 0.000 abstract description 2
- 239000012141 concentrate Substances 0.000 abstract 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 abstract 1
- 235000019659 mouth feeling Nutrition 0.000 abstract 1
- 239000002002 slurry Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 13
- 210000000936 intestine Anatomy 0.000 description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 11
- 241000186000 Bifidobacterium Species 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 230000000968 intestinal effect Effects 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 239000011575 calcium Substances 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 230000005176 gastrointestinal motility Effects 0.000 description 5
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 150000004804 polysaccharides Chemical class 0.000 description 5
- 230000036186 satiety Effects 0.000 description 5
- 235000019627 satiety Nutrition 0.000 description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000003613 bile acid Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 230000036449 good health Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 201000002313 intestinal cancer Diseases 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 229920000855 Fucoidan Polymers 0.000 description 2
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052745 lead Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- WTXGYGWMPUGBAL-SQOUGZDYSA-N (3r,4s,5r,6r)-3,4,5,6-tetrahydroxyoxepan-2-one Chemical compound O[C@@H]1COC(=O)[C@H](O)[C@@H](O)[C@@H]1O WTXGYGWMPUGBAL-SQOUGZDYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 201000003741 Gastrointestinal carcinoma Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000032177 Intestinal Polyps Diseases 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- 229940069978 calcium supplement Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013367 dietary fats Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 230000010030 glucose lowering effect Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 208000010501 heavy metal poisoning Diseases 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to the field of food technology, and in particular, to a seaweed dietary fiber jelly and a preparation method thereof.
- Dietary fiber is the seventh largest nutrient required by the human body, and is referred to as the "green scavenger" of the human body. Dietary fiber is a general term for edible plant ingredients, carbohydrates, and similar substances that are not digested and absorbed by the small intestine in the human body, but can be fermented in the large intestine. Dietary fiber can be divided into soluble dietary fiber and non-soluble dietary fiber. It plays an important role in maintaining a balanced diet and human health.
- Dietary fiber has a strong water absorption and swelling function. It absorbs water in the stomach and swells and forms a high viscosity sol or gel, which makes people feel full and helps to lose weight. It adjusts the pH of the intestine and improves the beneficial bacteria.
- dietary fiber can absorb bile acids, cholesterol Organic molecules such as mutants, inhibit the increase of total cholesterol (TC) concentration, reduce the synthesis and absorption of bile acid and its salts, lower the blood plasma and liver cholesterol levels, prevent coronary arteriosclerosis, cholelithiasis, and prevent cardiovascular and cerebrovascular diseases ; Can absorb glucose to slow absorption and inhibit glucagon secretion, so that it can fully exert the role of insulin and prevent diabetes.
- beneficial bacteria such as bifidobacteria and lactic acid bacteria
- TC total cholesterol
- dietary fiber can be exchanged with heavy metal ions such as Cu and Pb to relieve heavy metal poisoning. What's more important is that it can exchange with K + and Na + in the intestine, and promote a large amount of Na and K to be excreted in urine and feces, thereby reducing the ratio of Na + to K + in the blood and reducing blood pressure.
- the dietary elements of the Chinese people are mainly cereals, supplemented by vegetables and fruits, so there is no risk of dietary fiber deficiency, but with the improvement of living standards, the degree of food refinement is getting higher and higher, and the pace of life Faster and faster, the proportion of animal food has increased significantly.
- the proportion of heat production from dietary fat in some major cities has increased from 20% to 25% a few decades ago to the current 40% to 45%, while dietary fiber intake has decreased significantly.
- the present invention provides a seaweed dietary fiber jelly and a preparation method thereof.
- a seaweed dietary fiber jelly includes the following raw materials by weight: 0.5-5 parts of alginate, 0-5 parts of brown algae powder, 0-10 parts of kelp pulp, 0-3 parts of konjac powder, and inulin 0 -8 servings, 0-1 servings of xylooligosaccharides, 0-3 servings of fructo-oligosaccharides, 0-10 servings of isomalto-oligosaccharides, 0-10 servings of resistant dextrin, 0-10 servings of maltodextrin, and polydextrose 0 -8 parts, gels 0.3-3 parts and water 60-82 parts.
- the mass content of dietary fiber in the seaweed dietary fiber frozen is not less than 15%, the dietary fiber has low energy, produces satiety, promotes gastrointestinal motility, improves intestinal flora, and prevents constipation.
- the alginate is one or more of sodium alginate, potassium alginate and ammonium alginate, and the viscosity of the alginate is 500-1000 mPa.s, and the raw material is derived from giant algae .
- the mass content of L-fucose in the brown algae concentrated powder is greater than 15%, and the mass content of the sulfate group is greater than 10%.
- the brown algae concentrated powder After adding the brown algae concentrated powder, it is rich in active ingredients such as polysaccharides in brown algae So that the seaweed dietary fiber jelly has the effects of enhancing human immunity, lowering blood sugar, lowering blood lipids, and improving immunity.
- the gelling agent includes a calcium salt and a sustained-release component, and the gelling agent is a composite ingredient.
- the calcium salt is one or more of calcium sulfate, calcium carbonate, calcium lactate, and calcium hydrogen phosphate.
- the sustained-release component is one or more of sodium pyrophosphate, sodium tripolyphosphate, sodium hexametaphosphate, disodium pyrophosphate, citric acid, and gluconic acid-S-lactone. Species.
- a method for preparing algae dietary fiber jelly includes the following steps:
- step (2) the time for standing molding in step (2) is 1-5h, and the standing temperature is 10-40 ° C.
- the sterilization temperature is 80-90 ° C
- the time is 30-50min
- the shelf life can be at least 12 months.
- Alginate Sodium alginate, also known as alginate, is a natural polysaccharide substance extracted from brown algae, is a water-soluble natural dietary fiber, has unique gel characteristics, and does not decompose in the stomach. Increase satiety, dissolve gel in the intestine, adsorb heavy metals, expel toxins from the body, and promote gastrointestinal motility.
- alginate is a substance that has the function of removing lead, and can be used to make various foods.
- Brown algae concentrated powder is rich in fucoidan, is a water-soluble marine polysaccharide dietary fiber, and has important physiological functions, such as promoting gastrointestinal peristalsis, adsorbing toxic substances and accelerating elimination, especially adsorbing a variety of toxic Heavy metals such as Pb, Sn, Cd, etc., reduce the toxicity of these substances to the human body, and also have good effects on protecting the gastric mucosa, protecting the cardiovascular and cerebrovascular, anti-aging, improving immunity and suppressing tumors.
- Kelp pulp is a vegetable with high nutritional value and has certain medicinal value. In addition to being rich in iodine, calcium, potassium, alginic acid, and mannitol, it also contains a variety of vitamins and cellulose. Studies have found that kelp has a variety of biological functions such as lowering blood lipids, lowering blood sugar, regulating immunity, anticoagulation, antitumor, detoxifying lead and detoxifying, and antioxidant. Kelp pulp is made from fresh kelp through a special process and has the nutritional value and functional ingredients of kelp.
- Inulin has dual effects of dietary fiber and prebiotics, can regulate intestinal microbial flora, improve intestinal health, and prevent constipation. Inulin does not cause an increase in blood sugar, and can reduce blood lipids. It can effectively reduce serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), increase the high-density lipoprotein / low-density lipoprotein ratio, and improve blood lipids. . Inulin can promote the absorption of minerals, which can greatly improve Ca 2+, absorbent Mg 2 +, Zn 2 +, Cu 2+, Fe 2+ and the like minerals. It is reported that teenagers consume 8g / d for 8 weeks and 1 year, respectively. It was found that both significantly increased Ca absorption, and the body's bone mineral content and density also increased significantly.
- Resistant dextrin Low-molecular-weight water-soluble dietary fiber, which can increase the fiber content of food, delay human gastric emptying, form a mucous membrane in the stomach and intestines, slow down the digestion and absorption of food nutrients, and can also adsorb glucose Slowing its absorption, low blood sugar response, and long heat release time are good for weight control. It can also promote the proliferation of beneficial bacteria in the human intestine, improve the human intestinal environment, promote intestinal peristalsis, and prevent constipation.
- Isomalttooligosaccharide Water-soluble dietary fiber with low calorific value and anti-caries, also known as "bifidus factor”. Isomalttooligosaccharide can promote the proliferation of bifidobacteria in the intestine, inhibit the formation of harmful bacteria and putrefactive substances in the intestine, increase the vitamin content, and improve the body's immunity.
- Xylooligosaccharides also known as xylooligosaccharides, are functional polymeric sugars composed of 2-7 xylose molecules combined with (3-1, 4 glycoside bonds. It can be selectively Promote the proliferation activity of intestinal bifidobacteria. It is one of the species with the strongest function of proliferating bifidobacteria among polysaccharides. Its efficacy is nearly 10-20 times that of other polysaccharides. There is no low hydrolysis in the human gastrointestinal tract. Xylose enzymes can be directly entered into the large intestine and are preferably used by bifidobacteria. They promote the proliferation of bifidobacteria and simultaneously produce a variety of organic acids, reduce the pH of the intestine, inhibit the growth of harmful bacteria, and allow a large number of probiotics to multiply in the intestine. To achieve health benefits.
- Fructo-oligosaccharides are a water-soluble dietary fiber, which have a selective proliferation effect on beneficial bacteria in the intestine, such as bifidobacteria and lactobacillus, so that the beneficial bacteria have an advantage in the intestine and inhibit harmful
- beneficial bacteria such as bifidobacteria and lactobacillus
- the growth of bacteria reduces the formation of toxic substances and has a protective effect on intestinal mucosal cells and liver, thereby preventing the occurrence of diseased intestinal cancer and enhancing the body's immunity; it can effectively reduce the amount of serum cholesterol, triglycerides, and free fatty acids.
- a series of cardiovascular diseases such as hypertension and arteriosclerosis caused by high blood lipids have a better effect; at the same time, fructooligosaccharides are fermented by bacteria in the large intestine to produce L-lactic acid, which can dissolve calcium, magnesium, iron and other minerals. Promote the body's absorption of minerals.
- Konjac flour is rich in glucosides, is a high molecular compound, has strong water absorption, the volume can expand 80-100 times after water absorption, suppress appetite, produce satiety; and can absorb Cholesterol and bile acids have a certain effect on lowering blood pressure and reducing the incidence of cardiovascular disease; it can promote gastrointestinal motility, improve constipation, the colon, and accelerate the excretion of harmful substances in the body; maintaining normal blood glucose concentrations is beneficial to the prevention and improvement of diabetes.
- Polydextrose a new type of water-soluble dietary fiber that has the function of keeping the stomach and intestines unobstructed. It can also remove bile acids from the body, significantly reduce serum cholesterol, and cause satiety more easily. It can significantly reduce blood glucose levels after meals. Adjust the intestinal pH value, improve the reproduction environment of beneficial bacteria, and make beneficial bacteria such as bifidobacteria quickly Enlargement, thereby inhibiting the growth of saprophytic bacteria, and timely excreting toxins and metabolic wastes in the body to prevent the occurrence of diseases such as scabies, gastroenteritis, and colon cancer.
- the present invention utilizes the property of alginate to form a thermal irreversible gel with calcium ions, and adds inulin at the same time.
- the production process of the product of the invention is simple The operation is controllable.
- the present invention is rich in dietary fiber (mass content is not less than 15%), has low energy, and has good health effects on the human body.
- the present invention has a smooth taste, elasticity, rich in dietary fiber, low energy, convenient and ready-to-eat, various eating methods, and can be fried, steamed, fried, and cold-mixed.
- the addition of calcium salt, inulin and fructooligosaccharide can promote the absorption of Ca 2+ .
- the calcium alginate gel formed with alginate and calcium ions has satiety, intestines, and calcium supplementation. The four major effects of detoxification have good health functions for the human body.
- the product of the present invention has smooth, elastic texture, rich in dietary fiber, and has the effects of weight loss, promoting gastrointestinal motility, preventing constipation, adsorbing and discharging heavy metals, calcium supplement, blood lipid lowering, and blood glucose lowering effect; It is a new type of health meal replacement product and light food product with low y-g content and easy to eat. It is suitable for all ages and has good health functions for the human body.
- a kind of seaweed dietary fiber jelly the ingredients are: sodium alginate 300g, brown algae concentrated powder 100g, kelp pulp 300g , 50g konjac flour, 300g inulin, 50g xylooligosaccharides, 600g resistant dextrin, 200g isomalttooligosaccharides, 300g polydextrose and 110g gelling agent, the remaining water is 7690g.
- the brown algae concentrated powder market can be purchased, for example: Qingdao Mingyue Seaweed Group Co., Ltd. produces and sells brown algae concentrated powder;
- the gelling agent market can be purchased, for example: Qingdao Mingyue Seaweed Group Co., Ltd. produces and sells mixed nutrition.
- Strengthening agent, and the ratio of calcium sulfate dihydrate to sodium hexametaphosphate in the gel is 6-9: 1.
- a kind of seaweed dietary fiber jelly the ingredients are: potassium alginate 200g, brown algae concentrated powder 150g, kelp pulp 100g
- the brown algae concentrated powder market can be purchased, for example: Qingdao Mingyue Seaweed Group Co., Ltd. produces and sells brown algae concentrated powder;
- the gelling agent market can be purchased, for example: Qingdao Mingyue Seaweed Group Co., Ltd. produces and sells mixed nutrition A strengthening agent, and the ratio of calcium carbonate to glucono-6-lactone in the gel is 1: 3-5.
- a kind of seaweed dietary fiber jelly the ingredients are: sodium alginate 100g, brown algae concentrated powder 280g, kelp pulp 500g
- the brown algae concentrated powder market can be purchased, for example: Qingdao Mingyue Seaweed Group Co., Ltd. produces and sells brown algae concentrated powder;
- the gelling agent market can be purchased, for example: Qingdao Mingyue Seaweed Group Co., Ltd. produces and sells nutrition Enhancer, and the ratio of calcium hydrogen phosphate to gluconolactone in the gel is 1: 2-4.
- a kind of seaweed dietary fiber jelly the ingredients are: sodium alginate 100g, potassium alginate 50g, brown algae concentrated powder 50g
- the brown algae concentrated powder market can be purchased, for example: Qingdao Mingyue Seaweed Group Co., Ltd. produces and sells brown algae concentrated powder;
- the gelling agent market can be purchased, for example: Qingdao Mingyue Seaweed Group Co., Ltd. produces and sells mixed nutrition.
- Strengthening agent, and the ratio of calcium hydrogen phosphate: citric acid in the gel is 3-5: 1.
- Sodium alginate, potassium alginate, brown algae concentrated powder, inulin, resistant dextrin, polydextrose, isomalttooligosaccharide and maltodextrin were weighed and mixed thoroughly according to the above weight parts, and poured into 7100 g Stir in water at a high speed to prepare a homogeneous glue solution; then release 50g of gelling agent with 750g of water, shake it and add to the above homogeneous glue solution, stir quickly and homogeneously; fill and seal, and let stand at 20 ° C for 5h for sterilization.
- the sterilization condition is 80 ° C, 30 minutes, and the produced seaweed dietary fiber jelly can keep the quality for at least 12 months.
- the seaweed dietary fiber prepared in the embodiment of the present invention has a frozen taste, smoothness, elasticity, rich in various active ingredients, low energy, long shelf life, various eating methods, and can be fried, steamed, fried, and cold mixed. Eat whatever you want.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
一种海藻膳食纤维冻，包括以下重量份的原料：海藻酸盐0.5-5份，褐藻浓缩粉0-5份，海带浆0-10份，魔芋粉0-3份，菊粉0-8份，低聚木糖0-1份，低聚果糖0-3份，低聚异麦芽糖0-10份，抗性糊精0-10份，麦芽糊精0-10份，聚葡萄糖0-8份，凝胶剂0.3-3份和水60-82份。该产品口感爽滑、有弹性，富含膳食纤维，具有减肥、促进肠胃蠕动、预防便秘等功效；能量低、方便即食，是一款新型的保健代餐产品和轻食产品。
Description
一种海藻膳食纤维冻及其制备方法 技术领域
[0001] 本发明涉及食品技术领域， 尤其涉及一种海藻膳食纤维冻及其制备方法。
背景技术
[0002] 膳食纤维是人体所需的第七大营养素， 被称为人体“绿色清道夫”。 膳食纤维是 在人体内不被小肠消化吸收， 但能在大肠被发酵的可食用植物性成分、 碳水化 合物及相类似物质的总称， 膳食纤维可分为可溶性膳食纤维与非可溶性膳食纤 维。 它在维持膳食平衡及人体健康方面发挥着重要作用。
[0003] 膳食纤维具有较强的吸水功能和膨胀功能， 在肠胃中吸水膨胀并形成高粘度的 溶胶或凝胶， 使人产生饱腹感， 有利于减肥； 调节肠道 pH， 改善有益菌的繁殖 环境， 使双歧杆菌、 乳酸菌等有益菌增殖； 增加大便水分、 体积， 刺激肠道蠕 动， 利于粪便排出， 大大减少肠道癌和痨疮等的发病机率； 膳食纤维能吸附胆 汁酸、 胆固醇变异原等有机分子， 抑制总胆固醇 (TC) 浓度升高， 降低胆酸及 其盐类的合成与吸收， 降低人类体血浆和肝脏胆固醇水平， 防治冠状动脉硬化 、 胆石症和预防心脑血管疾病； 能吸附葡萄糖使吸收减慢， 抑制增血糖素分泌 ， 这样就可充分发挥胰岛素的作用， 防止糖尿病。 另外， 膳食纤维可与 Cu、 Pb 等重金属离子进行交换， 缓解重金属中毒。 更重要的是它能与肠道中的 K+、 Na +进行交换， 促使尿液和粪便中大量排出 Na、 K， 从而降低血液中的 Na+与 K+比 ， 产生降低血压的作用。
[0004] 我国人民的膳食素以谷类食物为主， 并辅以蔬菜果类， 所以本无膳食纤维缺乏 之虞， 但随着生活水平的提高， 食物精细化程度越来越高， 生活节奏越来越快 ， 动物性食物所占比例大为增加。 一些大城市居民膳食脂肪的产热比例， 已由 几十年前的 20%〜 25%增加至目前的 40%〜 45%， 而膳食纤维的摄入量却明显降 低， 所谓“生活越来越好， 纤维越来越少”。 据测算， 我国人均每日膳食纤维的实 际摄入量仅能达到 8~12g/d (在摄入 1斤蔬菜、 半斤水果的情况下)， 与我国营养学 会提出 25g/d摄入量相比， 摄入量严重不足， 由此导致一些所谓“现代文明病”，
如肥胖症、 糖尿病、 高脂血症等， 以及一些与膳食纤维过少有关的疾病， 如肠 癌、 便秘、 肠道息肉等发病率日渐增高。
[0005] 目前， 市场没有关于富含膳食纤维的冻产品， 因此研发一种安全卫生、 食用方 便、 富含膳食纤维并具有保健效果的海藻膳食纤维冻， 是一个急需解决的问题
发明概述
技术问题
问题的解决方案
技术解决方案
[0006] 为解决上述技术问题， 本发明提供一种海藻膳食纤维冻及其制备方法。
[0007] 为实现上述目的， 本发明采用下述技术方案：
[0008] 一种海藻膳食纤维冻， 包括以下重量份的原料： 海藻酸盐 0.5-5份， 褐藻浓缩粉 0-5份， 海带浆 0-10份， 魔芋粉 0-3份， 菊粉 0-8份， 低聚木糖 0-1份， 低聚果糖 0-3 份， 低聚异麦芽糖 0-10份， 抗性糊精 0-10份， 麦芽糊精 0-10份， 聚葡萄糖 0-8份， 凝胶剂 0.3-3份和水 60-82份。
[0009] 进一步地， 该海藻膳食纤维冻中的膳食纤维的质量含量不低于 15%， 膳食纤维 能量低， 产生饱腹感， 促进肠胃蠕动， 改善肠道菌群， 防止便秘。
[0010] 进一步地， 所述海藻酸盐为海藻酸钠、 海藻酸钾和海藻酸铵中的一种或多种， 所述海藻酸盐的粘度为 500- 1000mPa.s， 原料来源于巨藻。
[0011] 进一步地， 所述褐藻浓缩粉中的 L-岩藻糖质量含量大于 15%， 硫酸酯基团的质 量含量大于 10%， 添加褐藻浓缩粉后， 富含褐藻中的多糖等活性成分， 使得海藻 膳食纤维冻具有增强人体免疫力， 降血糖， 降血脂、 提升免疫力等功效。
[0012] 进一步地， 所述凝胶剂包括钙盐和缓释组分， 凝胶剂为一种复合配料。
[0013] 进一步地， 所述钙盐为硫酸钙、 碳酸钙、 乳酸钙和磷酸氢钙中的一种或多种。
[0014] 进一步地， 所述缓释组分为焦磷酸钠、 三聚磷酸钠、 六偏磷酸钠、 焦磷酸二氢 二钠、 柠檬酸和葡萄糖酸 -S-内酯中的一种或多种。
[0015] 一种海藻膳食纤维冻的制备方法， 包括以下步骤：
[0016] ( 1) 将一定量的海藻酸盐、 褐藻浓缩粉、 海带浆、 魔芋粉、 菊粉、 低聚木糖
、 低聚果糖、 低聚异麦芽糖、 抗性糊精、 麦芽糊精和聚葡萄糖充分混匀， 倒入 水中高速搅拌， 制备成均匀的胶液；
[0017] (2) 将质量比为 1 : 5-20的凝胶剂和水混合均勻， 再将其加入步骤 ⑴ 制得 的均匀胶液中， 快速搅拌均匀， 进行灌装封口；
[0018] (3) 静置成型后， 进行巴士杀菌， 制得成品。
[0019] 进一步地， 步骤 (2) 中静置成型的时间为 l-5h， 静置温度 10-40°C。
[0020] 进一步地， 步骤 (3) 中杀菌温度 80-90°C， 时间 30-50min， 能够保质至少 12个 月。
[0021] 海藻酸盐： 海藻酸钠又称褐藻胶， 是从褐藻中提取的一种天然多糖类物质， 是 一种水溶性天然膳食纤维， 具有独特凝胶特性， 在胃中不分解， 增加饱腹感， 到肠道中凝胶溶解， 吸附重金属， 排出体内毒素， 同时能促进肠胃蠕动。 1997 年， 我国以卫生部批准号“97-65”批准“褐藻胶”是具有排铅功能物质， 可以制作 各种食品。
[0022] 褐藻浓缩粉： 褐藻浓缩粉富含岩藻多糖， 是一种水溶性海洋多糖膳食纤维， 具 有重要的生理功能， 如促进肠胃蠕动， 吸附有毒物质并加速排除， 尤其是吸附 多种有毒重金属如 Pb、 Sn、 Cd等， 减少这些物质对人体的毒害， 另外对保护胃 黏膜、 保护心脑血管、 抗衰老、 提升免疫力及抑制肿瘤等方面也有很好的效果
[0023] 海带浆： 海带是一种营养价值很高的蔬菜， 同时具有一定的药用价值， 除含有 丰富的碘、 钙、 钾、 褐藻酸、 甘露醇外， 还含有多种维生素、 纤维素等， 研究 发现， 海带具有降血脂、 降血糖、 调节免疫、 抗凝血、 抗肿瘤、 排铅解毒和抗 氧化等多种生物功能。 海带浆是利用新鲜海带经过特殊工艺制作而成， 具有海 带所具有的营养价值及功效成分。
[0024] 菊粉： 菊粉具有膳食纤维和益生元双重功效， 能调节肠道微生物菌群， 改善肠 道健康， 防止便秘。 菊粉不会引起血糖升高， 且能降低血脂， 可有效降低血清 总胆固醇 (TC)和低密度脂蛋白胆固醇 (LDL-C)， 提高高密度脂蛋白 /低密度脂蛋白 比率， 改善血脂状况。 菊粉能促进矿物质吸收， 它能大大提高 Ca 2+、 Mg 2+、 Zn 2+、 Cu 2+、 Fe 2+等矿物质的吸收。 据报道， 青少年食用 8g/d分别 8周和 1年， 结果
发现， 都显著提高 Ca吸收， 而且身体的骨骼矿物质含量和密度也显著增加。
[0025] 抗性糊精： 低分子水溶性膳食纤维， 可增加食物的纤维含量， 延缓人体胃排空 ， 在胃肠中形成粘膜， 使食物营养素的消化吸收减慢， 同时也能通过吸附葡萄 糖而减慢其吸收， 血糖反应低， 热量释放时间长， 对控制体重有益。 还能促进 人体肠道中有益菌增殖， 改善人体肠道环境， 促进肠道蠕动， 预防便秘。
[0026] 低聚异麦芽糖： 水溶性膳食纤维， 热值低、 防龋齿， 又称为“双歧因子”。 低聚 异麦芽糖能促进肠道内双歧杆菌增殖， 抑制肠道有害菌及腐败物质形成， 增加 维生素含量， 提高机体免疫力。
[0027] 低聚木糖： 低聚木糖又称木寡糖， 是由 2-7个木糖分子以（3-1， 4糖苷键结合而成 的功能性聚合糖。 它可以选择性地促进肠道双歧杆菌的增殖活性， 是聚合糖类 中增殖双歧杆菌功能最强的品种之一， 它的功效性是其他聚合糖类的近 10-20倍 ， 人体胃肠道内没有水解低聚木糖的酶， 可直接进入大肠内优先为双歧杆菌所 利用， 促进双歧杆菌增殖同时产生多种有机酸， 降低肠道 pH值， 抑制有害菌生 长， 使益生菌在肠道大量增殖， 达到保健功效。
[0028] 低聚果糖： 低聚果糖是一种水溶性膳食纤维， 对肠道中有益菌群如双岐杆菌、 乳酸杆菌等有选择性增殖作用， 使有益菌群在肠道中占有优势， 抑制有害菌的 生长， 减少有毒物质的形成， 对肠粘膜细胞和肝具有保护作用， 从而防止病变 肠癌的发生， 增强机体免疫力； 能有效降低血清胆固醇、 甘油三脂、 游离脂肪 酸的数量， 对于因血脂高而引起的高血压、 动脉硬化等一系列心血管疾病有较 好的改善作用； 同时， 低聚果糖在大肠内被细菌发酵生成 L -乳酸， 可以溶解钙 、 镁、 铁等矿物质， 促进人体对矿物质的吸收。
[0029] 魔芋粉： 魔芋粉富含葡苷聚糖， 是一种高分子化合物， 具有很强的吸水性， 吸 水后体积可膨胀 80-100倍， 抑制食欲， 产生饱腹感； 并能吸附胆固醇和胆汁酸， 对降低血压减少心血管病发作有一定效用； 能促进肠胃蠕动， 改善便秘、 结肠 ， 加快排泄体内有害物质； 维持正常血糖浓度， 有益于糖尿病的预防和改善。
[0030] 聚葡萄糖： 一种新型的水溶性膳食纤维， 具有保持肠胃通畅的功能， 还可结合 清除体内的胆酸， 明显降低血清胆固醇， 更易引起饱腹感， 明显降低饭后血糖 水平， 能调节肠道 pH值， 改善有益菌的繁殖环境， 使双歧杆菌等有益菌群迅速
扩大， 从而抑制腐生菌生长， 并及时将体内毒素和代谢废物排泄， 达到预防痨 疮、 胃肠炎、 结肠癌等疾病的发生。
发明的有益效果
有益效果
[0031] 本发明的有益效果是，
[0032] ( 1) 本发明利用海藻酸盐遇钙离子形成热不可逆凝胶的特性， 同时添加菊粉
、 聚葡萄糖、 抗性糊精、 低聚木糖、 低聚果糖、 低聚异麦芽糖、 魔芋粉水溶性 膳食纤维和富含岩藻多糖的褐藻浓缩粉等有效成分， 本发明的产品制作工艺简 单， 操作可控。
[0033] (2) 配料中添加的海藻酸盐、 褐藻浓缩粉、 海带浆、 菊粉、 聚葡萄糖、 抗性 糊精、 低聚木糖、 低聚果糖、 低聚异麦芽糖、 魔芋粉等功能性原料， 具有减肥 、 促进肠胃蠕动、 预防便秘、 吸附和排出重金属、 补 、 降血脂、 降血糖等健 康功效。
[0034] (3) 本发明富含膳食纤维 (质量含量不低于 15%) ， 能量低， 对人体有很好 的保健作用。
[0035] (4) 本发明口感爽滑、 有弹性， 富含膳食纤维， 能量低、 方便即食， 食用方 法多样， 可煎炸蒸煮炒及凉拌。
[0036] (5) 本发明添加钙盐， 菊粉和低聚果糖能促进 Ca 2+的吸收， 另外以海藻酸盐 和钙离子形成的海藻酸钙凝胶具有饱腹、 润肠、 补钙、 排毒四大功效， 对人体 有很好的保健功能。
[0037] 综上所述， 本发明的产品口感爽滑、 有弹性， 富含膳食纤维， 具有减肥、 促进 肠胃蠕动、 预防便秘、 吸附和排出重金属、 补钙、 降血脂、 降血糖的功效； 育 g 量低、 方便即食， 是一款新型的保健代餐产品和轻食产品， 老少皆宜， 对人体 有很好的保健功能。
发明实施例
本发明的实施方式
[0038] 实施例 1
[0039] 一种海藻膳食纤维冻， 配料为： 海藻酸钠 300g， 褐藻浓缩粉 100g， 海带浆 300g
， 魔芋粉 50g， 菊粉 300g， 低聚木糖 50g， 抗性糊精 600g， 低聚异麦芽糖 200g， 聚葡萄糖 300g和凝胶剂 110g， 余量水 7690g。
[0040] 其中， 褐藻浓缩粉市场可购买到， 例如： 青岛明月海藻集团有限公司生产售卖 的褐藻浓缩粉； 凝胶剂市场可购买到， 例如： 青岛明月海藻集团有限公司生产 售卖的复配营养强化剂， 且凝胶剂中的二水硫酸钙与六偏磷酸钠比例为 6-9: 1。
[0041] 上述海藻膳食纤维冻的制备方法：
[0042] 先将海藻酸钠、 褐藻浓缩粉、 海带浆、 魔芋粉、 菊粉、 低聚木糖、 抗性糊精、 低聚异麦芽糖、 聚葡萄糖按照上述重量份称重并充分混匀， 倒入 6190g水中高速 搅拌， 制备成均匀胶液； 然后将 110g凝胶剂用 1500g水冲释， 摇匀后加入上述均 匀胶液中， 快速搅拌均匀； 灌装封口， 20°C静置成型 lh， 进行杀菌， 杀菌条件为 85°C， 30min, 制作出的海藻膳食纤维冻可以保质至少 12个月。
[0043] 实施例 2
[0044] 一种海藻膳食纤维冻， 配料为： 海藻酸钾 200g， 褐藻浓缩粉 150g， 海带浆 100g
， 魔芋粉 100g， 菊粉 500g， 抗性糊精 400g， 低聚果糖 100g， 聚葡萄糖 800g和凝 胶剂 80g， 余量水 7570g。
[0045] 其中， 褐藻浓缩粉市场可购买到， 例如： 青岛明月海藻集团有限公司生产售卖 的褐藻浓缩粉； 凝胶剂市场可购买到， 例如： 青岛明月海藻集团有限公司生产 售卖的复配营养强化剂， 且凝胶剂中的碳酸钙与葡萄糖酸 -6 -内酯比例为 1:3-5。
[0046] 上述海藻膳食纤维冻的制备方法：
[0047] 先将海藻酸钾、 褐藻浓缩粉、 海带浆、 魔芋粉、 菊粉、 抗性糊精、 低聚果糖、 聚葡萄糖按照上述重量份称重并充分混匀， 倒入 6870g水中高速搅拌， 制备成均 匀胶液； 然后将 80g凝胶剂用 700g水冲释， 摇匀后加入上述均匀胶液中， 快速搅 拌均勻； 灌装封口， 30°C静置成型 5h， 进行杀菌， 杀菌条件为 80°C， 50min， 制 作出的海藻膳食纤维冻可以保质至少 12个月。
[0048] 实施例 3
[0049] 一种海藻膳食纤维冻， 配料为： 海藻酸钠 100g， 褐藻浓缩粉 280g， 海带浆 500g
， 魔芋粉 220g， 菊粉 700g， 抗性糊精 150g， 低聚木糖 100g， 低聚果糖 50g， 低聚 异麦芽糖 400g， 聚葡萄糖 100g， 麦芽糊精 50g， 凝胶剂 40g， 余量水 7310g。
[0050] 其中， 褐藻浓缩粉市场可购买到， 例如： 青岛明月海藻集团有限公司生产售卖 的褐藻浓缩粉； 凝胶剂市场可购买到， 例如： 青岛明月海藻集团有限公司生产 售卖的复配营养强化剂， 且凝胶剂中的磷酸氢钙与葡萄糖酸内酯比例为 1:2-4。
[0051] 上述海藻膳食纤维冻的制备方法：
[0052] 先将海藻酸钠、 褐藻浓缩粉、 海带浆、 魔芋粉、 菊粉、 抗性糊精、 低聚木糖、 低聚果糖、 低聚异麦芽糖、 聚葡萄糖和麦芽糊精按照上述重量份称重并充分混 匀， 倒入 6510g水中高速搅拌， 制备成均匀胶液； 然后将 40g凝胶剂用 800g水冲 释， 摇匀后加入上述均匀胶液中， 快速搅拌均匀； 灌装封口， 40°C静置成型 3h， 进行杀菌， 杀菌条件为 90°C， 40min， 制作出的海藻膳食纤维冻可以保质至少 12 个月。
[0053] 实施例 4
[0054] 一种海藻膳食纤维冻， 配料为： 海藻酸钠 100g， 海藻酸钾 50g， 褐藻浓缩粉 50g
， 菊粉 300g， 抗性糊精 600g， 聚葡萄糖 500g， 低聚异麦芽糖 300g， 麦芽糊精 200 g， 凝胶剂 50g， 余量水 7850g。
[0055] 其中， 褐藻浓缩粉市场可购买到， 例如： 青岛明月海藻集团有限公司生产售卖 的褐藻浓缩粉； 凝胶剂市场可购买到， 例如： 青岛明月海藻集团有限公司生产 售卖的复配营养强化剂， 且凝胶剂中的磷酸氢钙:柠檬酸比例为 3-5: 1。
[0056] 上述海藻膳食纤维冻的制备方法：
[0057] 先将海藻酸钠、 海藻酸钾、 褐藻浓缩粉、 菊粉、 抗性糊精、 聚葡萄糖、 低聚异 麦芽糖和麦芽糊精按照上述重量份称重并充分混匀， 倒入 7100g水中高速搅拌， 制备成均匀胶液； 然后将 50g凝胶剂用 750g水冲释， 摇匀后加入上述均匀胶液中 ， 快速搅拌均匀； 灌装封口， 20°C静置成型 5h， 进行杀菌， 杀菌条件为 80°C， 30 min, 制作出的海藻膳食纤维冻可以保质至少 12个月。
[0058] 本发明实施例中所制作的海藻膳食纤维冻， 口感爽滑， 有弹性， 富含多种活性 成分， 且能量低、 保质期长， 食用方法多样， 可煎炸蒸煮炒及凉拌， 想怎么吃 就怎么吃。
[0059] 当然， 上述说明并非是对本发明的限制， 本发明也并不仅限于上述举例， 本技 术领域的技术人员在本发明的实质范围内所做出的变化、 改型、 添加或替换，
也应属于本发明的保护范围。
Claims
[权利要求 1] 一种海藻膳食纤维冻， 其特征在于， 包括以下重量份的原料： 海藻酸 盐 0.5-5份， 褐藻浓缩粉 0-5份， 海带浆 0-10份， 魔芋粉 0-3份， 菊粉 0-8 份， 低聚木糖 0-1份， 低聚果糖 0-3份， 低聚异麦芽糖 0-10份， 抗性糊 精 0-10份， 麦芽糊精 0-10份， 聚葡萄糖 0-8份， 凝胶剂 0.3-3份和水 60-8 2份。
[权利要求 2] 如权利要求 1所述的一种海藻膳食纤维冻， 其特征在于， 该海藻膳食 纤维冻中的膳食纤维的质量含量不低于 15%。
[权利要求 3] 如权利要求 1所述的一种海藻膳食纤维冻， 其特征在于， 所述海藻酸 盐为海藻酸钠、 海藻酸钾和海藻酸铵中的一种或多种， 所述海藻酸盐 的粘度为 500-1000mPa.s， 原料来源于巨藻。
[权利要求 4] 如权利要求 1所述的一种海藻膳食纤维冻， 其特征在于， 所述褐藻浓 缩粉中的 L-岩藻糖质量含量大于 15%， 硫酸酯基团的质量含量大于 10 %。
[权利要求 5] 如权利要求 1所述的一种海藻膳食纤维冻， 其特征在于， 所述凝胶剂 包括钙盐和缓释组分。
[权利要求 6] 如权利要求 5所述的一种海藻膳食纤维冻， 其特征在于， 所述钙盐为 硫酸钙、 碳酸钙、 乳酸钙和磷酸氢钙中的一种或多种。
[权利要求 7] 如权利要求 5所述的一种海藻膳食纤维冻， 其特征在于， 所述缓释组 分为焦磷酸钠、 三聚磷酸钠、 六偏磷酸钠、 焦磷酸二氢二钠、 柠檬酸 和葡萄糖酸 -S-内酯中的一种或多种。
[权利要求 8] 如权利要求 1-7中任一所述的海藻膳食纤维冻的制备方法， 其特征在 于， 包括以下步骤：
( 1) 将一定量的海藻酸盐、 褐藻浓缩粉、 海带浆、 魔芋粉、 菊粉、 低聚木糖、 低聚果糖、 低聚异麦芽糖、 抗性糊精、 麦芽糊精和聚葡萄 糖充分混匀， 倒入水中高速搅拌， 制备成均匀的胶液；
(2) 将质量比为 1 : 5-20的凝胶剂和水混合均匀， 再将其加入步骤 ( 1) 制得的均匀胶液中， 快速搅拌均匀， 进行灌装封口；
(3) 静置成型后， 进行巴士杀菌， 制得成品。
[权利要求 9] 如权利要求 8所述的海藻膳食纤维冻的制备方法， 其特征在于， 步骤
(2) 中静置成型的时间为 l-5h， 静置温度 10-40°C。
[权利要求 10] 如权利要求 8所述的海藻膳食纤维冻的制备方法， 其特征在于， 步骤
(3) 中杀菌温度 80-90°C， 时间 30-50min。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810566426.1A CN108813444A (zh) | 2018-06-05 | 2018-06-05 | 一种海藻膳食纤维冻及其制备方法 |
| CN201810566426.1 | 2018-06-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2019233202A1 true WO2019233202A1 (zh) | 2019-12-12 |
Family
ID=64143703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2019/083608 WO2019233202A1 (zh) | 2018-06-05 | 2019-04-22 | 一种海藻膳食纤维冻及其制备方法 |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN108813444A (zh) |
| WO (1) | WO2019233202A1 (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111280417A (zh) * | 2020-03-19 | 2020-06-16 | 枣庄学院 | 一种富含膳食纤维的双层多味果冻及其制备方法 |
| CN115349614A (zh) * | 2022-08-15 | 2022-11-18 | 宝得瑞（湖北）健康产业有限公司 | 一种稳定性良好的速溶营养南瓜粉及其制备方法 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108813444A (zh) * | 2018-06-05 | 2018-11-16 | 青岛明月海藻生物科技有限公司 | 一种海藻膳食纤维冻及其制备方法 |
| CN110226749A (zh) * | 2019-06-12 | 2019-09-13 | 青岛明月海藻生物健康科技集团有限公司 | 一种茶凝胶食品及其制备方法 |
| CN110623187A (zh) * | 2019-10-28 | 2019-12-31 | 青岛明月海藻生物健康科技集团有限公司 | 富含岩藻多糖的固体饮料及在清除幽门螺旋杆菌中的应用 |
| CN110897111A (zh) * | 2019-11-07 | 2020-03-24 | 青岛明月海藻生物健康科技集团有限公司 | 一种海藻酸钙冷工艺吸吸冻及其制备方法 |
| CN112089030A (zh) * | 2020-10-19 | 2020-12-18 | 威海世纪博康海藻有限公司 | 具有减肥作用的组合物、保健食品及其制备方法 |
| CN115633767A (zh) * | 2022-09-26 | 2023-01-24 | 宁波大学 | 一种具有排铅功能的桃膳食纤维果冻及其制备方法和应用 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101422212A (zh) * | 2008-12-10 | 2009-05-06 | 青岛明月海藻集团有限公司 | 一种海藻酸盐凉粉及制作方法 |
| CN102150767A (zh) * | 2010-12-23 | 2011-08-17 | 青岛明月海藻集团有限公司 | 一种热溶后形成热不可逆凝胶的复合食用胶材料及其制备方法 |
| CN102239978A (zh) * | 2011-07-07 | 2011-11-16 | 何家庆 | 一种魔芋枸杞果冻及其制备方法 |
| CN102783589A (zh) * | 2012-08-28 | 2012-11-21 | 青岛海之林生物科技开发有限公司 | 一种复配凝胶粉及应用 |
| CN102805279A (zh) * | 2012-08-28 | 2012-12-05 | 青岛海之林生物科技开发有限公司 | 一种海藻酸钠果冻粉及应用 |
| WO2014009155A1 (en) * | 2012-07-13 | 2014-01-16 | Unilever N.V. | Gelled food concentrate comprising pectin gel |
| CN108813444A (zh) * | 2018-06-05 | 2018-11-16 | 青岛明月海藻生物科技有限公司 | 一种海藻膳食纤维冻及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1163724A (zh) * | 1996-04-30 | 1997-11-05 | 李锡庆 | 一种用褐藻酸钠制造凉粉的方法 |
| CN103053904A (zh) * | 2012-12-29 | 2013-04-24 | 北京中科邦尼国际科技有限责任公司 | 一种具有调节肠道菌群功能的复合功能糖 |
| CN106262377A (zh) * | 2016-09-30 | 2017-01-04 | 青岛明月海藻生物科技有限公司 | 一种褐藻高钙凝胶糕及制备方法 |
| CN106690331A (zh) * | 2016-11-21 | 2017-05-24 | 北京世纪博康医药科技有限公司 | 一种海带膳食纤维颗粒及其制备方法 |
| CN114052261A (zh) * | 2016-11-21 | 2022-02-18 | 南京世纪博康医药科技有限公司 | 磷脂在降低海带膳食纤维片脆碎度及改善口感方面的应用 |
-
2018
- 2018-06-05 CN CN201810566426.1A patent/CN108813444A/zh active Pending
-
2019
- 2019-04-22 WO PCT/CN2019/083608 patent/WO2019233202A1/zh active Application Filing
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101422212A (zh) * | 2008-12-10 | 2009-05-06 | 青岛明月海藻集团有限公司 | 一种海藻酸盐凉粉及制作方法 |
| CN102150767A (zh) * | 2010-12-23 | 2011-08-17 | 青岛明月海藻集团有限公司 | 一种热溶后形成热不可逆凝胶的复合食用胶材料及其制备方法 |
| CN102239978A (zh) * | 2011-07-07 | 2011-11-16 | 何家庆 | 一种魔芋枸杞果冻及其制备方法 |
| WO2014009155A1 (en) * | 2012-07-13 | 2014-01-16 | Unilever N.V. | Gelled food concentrate comprising pectin gel |
| CN102783589A (zh) * | 2012-08-28 | 2012-11-21 | 青岛海之林生物科技开发有限公司 | 一种复配凝胶粉及应用 |
| CN102805279A (zh) * | 2012-08-28 | 2012-12-05 | 青岛海之林生物科技开发有限公司 | 一种海藻酸钠果冻粉及应用 |
| CN108813444A (zh) * | 2018-06-05 | 2018-11-16 | 青岛明月海藻生物科技有限公司 | 一种海藻膳食纤维冻及其制备方法 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111280417A (zh) * | 2020-03-19 | 2020-06-16 | 枣庄学院 | 一种富含膳食纤维的双层多味果冻及其制备方法 |
| CN115349614A (zh) * | 2022-08-15 | 2022-11-18 | 宝得瑞（湖北）健康产业有限公司 | 一种稳定性良好的速溶营养南瓜粉及其制备方法 |
| CN115349614B (zh) * | 2022-08-15 | 2024-04-16 | 宝得瑞（湖北）健康产业有限公司 | 一种稳定性良好的速溶营养南瓜粉及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108813444A (zh) | 2018-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2019233202A1 (zh) | 一种海藻膳食纤维冻及其制备方法 | |
| CN101606704B (zh) | 一种具有多种功能作用的膳食纤维食品 | |
| CN111084389A (zh) | 一种膳食纤维复合粉及其制备方法 | |
| CN106690290A (zh) | 一种高膳食纤维全营养特殊医学用途配方食品及其制备方法 | |
| CN105475430A (zh) | 一种魔芋膳食纤维保健饼干及其制备方法 | |
| WO2022016774A1 (zh) | 利于调节肠道、促进消化、改善便秘的组合物及其制备方法 | |
| CN105876584A (zh) | 固体饮料及其制备方法 | |
| CN105341104A (zh) | 一种紫薯山药保健饼干及其制备方法 | |
| CN108450937A (zh) | 一种养胃并增强免疫力的减肥代餐粉及其制备方法 | |
| CN108208741B (zh) | 一种功能性食用盐、低钠盐及咸味调味料及其制备方法 | |
| CN110623270A (zh) | 一种活力餐及其制备方法 | |
| CN101176553A (zh) | 一种新鲜水果魔芋功能性食品及其制备方法 | |
| CN106805065A (zh) | 一种菊粉富硒固体饮料 | |
| CN107788436A (zh) | 一种降脂减肥的组合物 | |
| CN112136894A (zh) | 有益心血管健康的营养膳食补充食品及其制备方法、应用 | |
| CN114711374A (zh) | 酵纤复合营养素粉及其制备方法 | |
| CN106070984A (zh) | 一种含益生元的软糖及其制备方法 | |
| KR101496244B1 (ko) | 발효 치커리를 이용한 변비 개선용 기능성 음료 제조방법 및 조성물 | |
| CN116584597A (zh) | 一种改善肠道功能的西梅饮品配方及其制备方法 | |
| CN111887275A (zh) | 一种具有减肥益肠生酮的魔芋蛋白酥及其制备方法 | |
| CN110897111A (zh) | 一种海藻酸钙冷工艺吸吸冻及其制备方法 | |
| CN101716003B (zh) | 膳食纤维系列口服液 | |
| KR20060024766A (ko) | 혈중 저분자량질소함유화합물의 농도를 저감시키는질병개선용식품 | |
| CN109673906A (zh) | 一种复合膳食纤维粉及其制备方法 | |
| KR20160113867A (ko) | 변비 개선용 조성물 및 이로 제조된 건강식품 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19814666 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 19814666 Country of ref document: EP Kind code of ref document: A1 |